OTC Healthcare Stock Alert: Comprehensive Care (OTCBB: CHCR) Six Month Financial Results; Revenues of $36 Million, Earnings of $1.7 Million or $0.02 Per Share

TAMPA, Fla. - August 14, 2012 (Investorideas.com newswire) OTC Healthcare stock alert - Comprehensive Care Corporation (OTCBB: CHCR), a leading behavioral health, substance abuse and psychotropic pharmacy management services provider for managed care companies throughout the U.S., reports earnings of $1.7 million for the six months ended June 30, 2012. Earnings per diluted common share were $0.02. This compares to a $3.9 million loss in the first six months of 2011 and a $.07 loss per common share.

The Company announced that operating income for the first half of 2012 totaled $2.1 million compared to an operating loss of $3.1 million in the same period in 2011. While revenues for the first six months declined slightly from $36.8 million in 2011 to $36.0 million in 2012, the cost of revenues decreased 13.9 percent from $35.3 million in 2011 to $30.4 million in the comparable period in 2012.
"The cost saving measures we accomplished earlier this year, with mid-level and senior executives taking salary reductions, and some layoffs, combined with ending contracts that were not profitable for CompCare, are paying rewards. For the first six months of 2012, we were profitable, cash flow positive and were able to increase operating income and reduce our general and administrative expenses from $4.1 million in the first half of 2011 to $2.7 million for the comparable period this year," said Clark Marcus, Chairman and CEO.
"I am especially pleased that our pharmacy management contracts were up 18.9 percent, or $3.1 million, to $19.4 million in the first six months of 2012 compared to the previous year due to a 3.6 percent increase in membership and an 11 percent contract rate increase with the health plan we serve in Puerto Rico. We truly believe our strategies to reduce pharmaceutical costs for our clients will be a key element for our future growth," Mr. Marcus said.
"I am very proud of these financial results and the fact that CompCare's management team has solidified the foundation of the Company, improving it to support our growth. We have added senior level consultants with track records of success and we are dedicated to provide our shareholders continued growth in the future," Mr. Marcus concluded.
About CompCare:
Established in 1969, CompCare provides behavioral health, substance abuse and psychotropic pharmacy management services for managed care companies throughout the United States. Headquartered in Tampa, Florida, CompCare focuses on personalized attention, flexibility, a commitment to high-quality services and innovative approaches to behavioral health that address both the specific needs of clients and changing healthcare industry demands. For more information, please call 813-288-4808 or visit our website at www.compcare.com.
Forward-Looking Statements
Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond CompCare's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, the ability of CompCare to maximize its market share with new pharmacy initiatives, the ability of CompCare and its staff to execute its business plan, the ability of CompCare to offer and sell any of its products at a profit, changes in local, regional, and national economic and political conditions, the effect of governmental regulation, competitive market conditions, varying trends in member utilization, our ability to manage healthcare operating expenses, our ability to achieve expected results from new business, the profitability, if any, of our capitated contracts or other products, increases or variations in cost of care, seasonality, CompCare's ability to obtain additional financing, increased outsourcing of behavioral health services, and additional risk factors as discussed in the reports filed by the company with the Securities and Exchange Commission, which are available on its website at www.sec.gov. Any forward- looking statement in this release speaks only as of the date on which it is made. CompCare assumes no obligation to update or revise any forward-looking statements.
Investor Contacts:
Paul Knopick
E & E Communications
pknopick@eandecommunications.com
940.262.3584
Published at Investorideas.com Newswire
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
Disclosure: Investorideas.com is compensated for publishing and distributing news for CHCR: four thousand for one month by third party IR firm
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Beverage and Nutrition Stock (OTC: HRDN) - "Significant Market Opportunity in Functional Beverages"

New York, New York - August 14, 2012 (Investorideas.com newswire) Beverage stocks research: Investorideas.com, an investor research portal specializing in sector research including beverage and nutrition stocks releases recent CFA commentary on DC Brands International Inc. (OTC: HRDN).

Patrick J. Murphy of Murphy Analytics LLC, a provider of sponsored research coverage on smallcap stocks , discusses the market opportunity moving forward .
"With a broad portfolio of dry supplements and the Company's patented and licensed flip top cap compartment used in the functional beverage product line, HRDN has a product lineup that gives the company the opportunity to drive sales in its target retail, online and international markets. "
Report:

Select Stock Trading Data
Recent Stock Price:	$0.0040
Shares Outstanding:	485 million
Float	3.3 million
Recent Market Cap:	$1.94 million
52 Week Range:	$0.004 - $0.90
Exchange:	OTCBB
Ticker:	HRDN
URL:	http://www.hardnutrition.com
Data sourced from Yahoo! Finance; otcbb.com; Company filings

DC Brands International, a publicly traded company under the ticker symbol HRDN, presently specializes in the manufacturing of its functional beverages and health products. Established in 1998, DC Brands began producing a number of lines of energy drinks in 2005. DC Brands then purchased the assets of H.A.R.D. Nutrition and began its quest to produce a new health line of products. DC Brands has recently announced the release of its new H.A.R.D. Nutrition Functional Water Systems, which it expects will revolutionize the functional beverage category.
H.A.R.D. Nutrition products are designed with the concept that increasing healthiness begins with sticking to a diet, increasing exercise and adding supplements to work with the person's diet and exercise regimen. Marketing for this product lineup captures this triangular approach to health and wellness in the Company's trademarked saying: "Life Won't Change Until You Change Your Life."™ Products are developed based on the Company's philosophy that cleaning the body and getting rid of toxins is the only way to get optimal results from the body, diet, training and supplements. HRDN has developed these products with the help of over 100 athletes combined with the most modern testing equipment available. HRDN products are categorized as follows:

• Dry Supplements
• Functional Beverages
• Online Sales
• International Sales

Dry supplements are designed to address performance, energy, recovery, strength, therapeutic needs, cleansing, weight loss, and wellness. These dry supplements serve as the foundation for the other three product categories. HRDN's functional beverage products utilize the supplements in dry form by placing them in a container built into each lid. Additionally, the Company has developed a unique, lightly flavored water which was formulated to act as a catalyst for the enclosed supplements, creating a functional system designed to provide the body with all the nutrients needed to deliver the desired results. Functional beverages products include:

• Cleanz+: designed to help with the cleaning of the colon, kidneys and liver, plus improves digestive health and immune function.
• Fix It: designed to helps reduce inflammation, ease tendonitis and break down mineral deposits that cause pain in the joints as well as keeping the tendons supple.
• Health+: designed to provide everything a body needs throughout the day to stay on track and be productive.
• Fat Fighter: a powerful blend of ingredients designed to help suppress appetite and reduce sugar cravings.
• Feel Better: a proprietary blend of vitamins, minerals and herbs designed to replace what strenuous exercise takes out of the body.
• Whacked Energy: formulated to lift a person up and keep them going without the sugar crash of traditional energy drinks.
• Think!: a proprietary blend of vitamins, minerals and other ingredients designed to recharge the brain and body.
• WIN!: formulated to increase endurance and stamina throughout the entire workout.

In gauging the general market opportunity in a June 2012(i) investor presentation, market leader GNC referenced a Nutrition Business Journal's Supplement Business Report 2011 in which it was estimated that 51% of physicians regularly use vitamins, minerals, herbs and supplements (VMHS) while 79% regularly subscribe VMHS to their patients. This interest in quality of life and addressing a broad array of consumer needs is reflected in a market that Nutrition Business Journal estimates(ii) grew to $28.1 billion in 2010 and a global nutrition industry that has reached $226 billion.(iii) While this general market opportunity already has become quite large, GNC again cites NBJ estimates of 3.1% growth annually for 2010-2017 for vitamins and 5.8% growth annually for 2010 - 2017 for sports nutrition. GNC attributes this growth both to a broadening of the sports nutrition space as well as growth in the general VMHS category both of which create an opportunity to attract younger, higher spending customers for life.
In a June 2012 presentation,(iv) Vitamin Shoppe echoed the optimism for the general market opportunity while citing an NBJ estimate that e-commerce for VMHS will grow at a compound annual growth rate of 16.2% from 2003 to 2015, when online sales are expected to reach $34 billion. Addressing the fragmented nature of the market, VSI cites the NBJ estimate that market leaders Whole Foods, GNC, Vitamin Shoppe and Vitamin World together hold a market share of approximately 11.3%.
With a broad portfolio of dry supplements and the Company's patented and licensed flip top cap compartment used in the functional beverage product line, HRDN has a product lineup that gives the company the opportunity to drive sales in its target retail, online and international markets. As HRDN begins to increase distribution beyond its core market in Colorado through arrangements such as the recently announced agreement with a national sales and brokerage company, there is an opportunity to gain share in the highly fragmented vitamins, minerals, herbs and supplement market. In a recent letter to shareholders, President and CEO Stephen Horgan addressed HRDN's strategy going forward, emphasizing the attractive market size and the Company's opportunity to gain share:
"I believe the success of our business going forward will also depend on two things: our ability to distribute our product in key markets and retailers; and then our ability to accelerate revenue and fuel that demand. We have put in place a relationship that we expect will expand our distribution capabilities nationally. This relationship will immediately expand our reach far beyond DC Brands' historic Colorado market and believe it will be a solid, initial step towards the success of the business…The functional beverage space continues to be a strong and growing multi-billion dollar industry. We have an exceptional product in HARD Nutrition that we believe is uniquely positioned to compete and succeed in this category."
Patrick Murphy Bio:
Patrick J. Murphy is the owner of Murphy Analytics LLC, a provider of sponsored research coverage on smallcap stocks. Mr. Murphy has nearly 20 years of capital markets experience providing institutional investment and transaction analysis across a range of asset classes including microcap equities, commercial real estate debt and equity, municipal derivatives and public finance, venture capital, fixed income, CMBS and mortgage REIT's. In addition to his work with Murphy Analytics, Mr. Murphy also serves as a consultant to a municipal derivatives advisory firm. Mr. Murphy is an alumnus of the University of Notre Dame (1991), with an undergraduate degree in Economics, and earned a Masters Degree in Finance from St. Louis University in 1997. Mr. Murphy is a CFA Charterholder and a member of the CFA Society of St. Louis.
Patrick Murphy Disclaimer:
Readers are advised that the above article is solely for information purposes and should not to be construed as an offer to sell or the solicitation of an offer to buy any security. The views expressed herein are based upon the author's analysis of the issuer's public disclosures, and assumes both their accuracy and completeness. The opinions and statements included herein are based on sources (including the companies discussed and public sources) believed to be reliable and in good faith, but no representation or warranty, express or implied, is made as to their accuracy, completeness or correctness. The author has not independently verified the information contained herein. This information is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. You should review a complete information package on all companies, which should include, but not be limited to, the Company's annual report, quarterly reports, press releases and all regulatory filings. The foregoing discussion contains statements which are based on current expectations, estimates and projections, and differences from such expectations, estimates and projections can be expected. The author, Patrick Murphy, was compensated $510 by InvestorIdeas.com for writing this article. Murphy does not own shares of any of the companies mentioned in this article. Mr. Murphy's research firm, Murphy Analytics, may be engaged for the provision of a research report on the Company in the future.
i http://phx.corporate-ir.net/phoenix.zhtml?c=88669&p=irol-presentations
ii http://newhope360.com/nutrition-business-journal
iii http://newhope360.com/us-functional-food-and-beverage-sales-growth-2000-2013e-0
iv http://www.vitaminshoppe.com/content/en/support/help/investors.jsp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer / Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
http://www.investorideas.com/About/Disclaimer.asp
Disclosure: Investorideas.com and its SMS partner Running Bull OTC have been compensated by HRDN for one month of news, email and sms: twenty five thousand  
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
DC Brands is featured on Running Bull OTC for SMS alerts - sign up for the ap with your Android; Blackberry coming soon!
http://www.runningbullotc.com/
Contact HRDN: Wade Brantley
wbrantley@dc-brands.com
www.hardnutrition.com
Contact Investorideas.com 800 665 0411

NASDAQ Top Percentage Gainers: FSII, ALXA, GAI, PVSW

New York, New York - August 13, 2012 (Investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research issues a trading alert for the top percentage gainers on the NASDAQ for mid-day trading August 13th.

Leading the top gainers, FSI International Inc. (NasdaqGS: FSII) is trading at $6.16 , soaring 2.12 or 52.48% as of 1:35PM EDT on over 16 Million shares following acquisition news. Tokyo Electron Limited;(TSE:8035) and FSI International, Inc. (FSII), announced today that they have entered into a definitive agreement under which TEL will acquire FSI for $6.20 per share in cash, or an aggregate equity purchase price of approximately $252.5 million.
Alexza Pharmaceuticals Inc. (NasdaqGM: ALXA) is trading at $4.05, gaining $1.09 or 36.82% as of 1:39PM EDT on over 1.6 Million shares.
Global-Tech Advanced Innovations Inc. (NasdaqGM: GAI) makes the top gainers list trading at $6.40, moving $1.40 or 28.00% as of 12:40PM EDT on light volume .
Pervasive Software Inc. (NasdaqGM: PVSW) is trading up at $8.01, adding $1.46 or 22.29% as of 1:41PM EDT on over 240,000 shares.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts. Sectors include biotech stocks, tech stocks, beverage stocks, mining stocks, water, renewable energy, oil and gas.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access 13 online stock directories
http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411
Source - www.Investorideas.com

Renewable Energy Stock Alert: Solar Stock Ascent Solar (ASTI) Soars On News of EnerPlex Solar Powered Charger for Samsung® Galaxy S III

TAMPA, Fla. - August 13, 2012 (Investorideas.com newswire) Comprehensive Care Corporation ("CompCare" or the "Company") (OTCBB: CHCR), a leading behavioral health, substance abuse and psychotropic pharmacy management services provider for managed care companies throughout the U.S., today announced earnings of $1.7 million for the six months ended June 30, 2012. Earnings per diluted common share were $0.02. This compares to a $3.9 million loss in the first six months of 2011 and a $.07 loss per common share.

The Company announced that operating income for the first half of 2012 totaled $2.1 million compared to an operating loss of $3.1 million in the same period in 2011. While revenues for the first six months declined slightly from $36.8 million in 2011 to $36.0 million in 2012, the cost of revenues decreased 13.9 percent from $35.3 million in 2011 to $30.4 million in the comparable period in 2012.
"The cost saving measures we accomplished earlier this year, with mid-level and senior executives taking salary reductions, and some layoffs, combined with ending contracts that were not profitable for CompCare, are paying rewards. For the first six months of 2012, we were profitable, cash flow positive and were able to increase operating income and reduce our general and administrative expenses from $4.1 million in the first half of 2011 to $2.7 million for the comparable period this year," said Clark Marcus, Chairman and CEO.
"I am especially pleased that our pharmacy management contracts were up 18.9 percent, or $3.1 million, to $19.4 million in the first six months of 2012 compared to the previous year due to a 3.6 percent increase in membership and an 11 percent contract rate increase with the health plan we serve in Puerto Rico. We truly believe our strategies to reduce pharmaceutical costs for our clients will be a key element for our future growth," Mr. Marcus said.
"I am very proud of these financial results and the fact that CompCare's management team has solidified the foundation of the Company, improving it to support our growth. We have added senior level consultants with track records of success and we are dedicated to provide our shareholders continued growth in the future," Mr. Marcus concluded.
About CompCare:
Established in 1969, CompCare provides behavioral health, substance abuse and psychotropic pharmacy management services for managed care companies throughout the United States. Headquartered in Tampa, Florida, CompCare focuses on personalized attention, flexibility, a commitment to high-quality services and innovative approaches to behavioral health that address both the specific needs of clients and changing healthcare industry demands. For more information, please call 813-288-4808 or visit our website at www.compcare.com.
Forward-Looking Statements
Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond CompCare's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, the ability of CompCare to maximize its market share with new pharmacy initiatives, the ability of CompCare and its staff to execute its business plan, the ability of CompCare to offer and sell any of its products at a profit, changes in local, regional, and national economic and political conditions, the effect of governmental regulation, competitive market conditions, varying trends in member utilization, our ability to manage healthcare operating expenses, our ability to achieve expected results from new business, the profitability, if any, of our capitated contracts or other products, increases or variations in cost of care, seasonality, CompCare's ability to obtain additional financing, increased outsourcing of behavioral health services, and additional risk factors as discussed in the reports filed by the company with the Securities and Exchange Commission, which are available on its website at www.sec.gov. Any forward- looking statement in this release speaks only as of the date on which it is made. CompCare assumes no obligation to update or revise any forward-looking statements.
Investor Contacts:
Paul Knopick
E & E Communications
pknopick@eandecommunications.com
940.262.3584

Published at Investorideas.com Newswire

Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
Disclosure: Investorideas.com is compensated for publishing and distributing news for CHCR: four thousand for one month by third party IR firm
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Healthcare Stock News: Comprehensive Care Corporation (OTCBB: CHCR) Announces Profitable Six Month Financial Results

TAMPA, Fla. - August 13, 2012 (Investorideas.com newswire) Comprehensive Care Corporation ("CompCare" or the "Company") (OTCBB: CHCR), a leading behavioral health, substance abuse and psychotropic pharmacy management services provider for managed care companies throughout the U.S., today announced earnings of $1.7 million for the six months ended June 30, 2012. Earnings per diluted common share were $0.02. This compares to a $3.9 million loss in the first six months of 2011 and a $.07 loss per common share.

The Company announced that operating income for the first half of 2012 totaled $2.1 million compared to an operating loss of $3.1 million in the same period in 2011. While revenues for the first six months declined slightly from $36.8 million in 2011 to $36.0 million in 2012, the cost of revenues decreased 13.9 percent from $35.3 million in 2011 to $30.4 million in the comparable period in 2012.
"The cost saving measures we accomplished earlier this year, with mid-level and senior executives taking salary reductions, and some layoffs, combined with ending contracts that were not profitable for CompCare, are paying rewards. For the first six months of 2012, we were profitable, cash flow positive and were able to increase operating income and reduce our general and administrative expenses from $4.1 million in the first half of 2011 to $2.7 million for the comparable period this year," said Clark Marcus, Chairman and CEO.
"I am especially pleased that our pharmacy management contracts were up 18.9 percent, or $3.1 million, to $19.4 million in the first six months of 2012 compared to the previous year due to a 3.6 percent increase in membership and an 11 percent contract rate increase with the health plan we serve in Puerto Rico. We truly believe our strategies to reduce pharmaceutical costs for our clients will be a key element for our future growth," Mr. Marcus said.
"I am very proud of these financial results and the fact that CompCare's management team has solidified the foundation of the Company, improving it to support our growth. We have added senior level consultants with track records of success and we are dedicated to provide our shareholders continued growth in the future," Mr. Marcus concluded.
About CompCare:
Established in 1969, CompCare provides behavioral health, substance abuse and psychotropic pharmacy management services for managed care companies throughout the United States. Headquartered in Tampa, Florida, CompCare focuses on personalized attention, flexibility, a commitment to high-quality services and innovative approaches to behavioral health that address both the specific needs of clients and changing healthcare industry demands. For more information, please call 813-288-4808 or visit our website at www.compcare.com.
Forward-Looking Statements
Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond CompCare's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, the ability of CompCare to maximize its market share with new pharmacy initiatives, the ability of CompCare and its staff to execute its business plan, the ability of CompCare to offer and sell any of its products at a profit, changes in local, regional, and national economic and political conditions, the effect of governmental regulation, competitive market conditions, varying trends in member utilization, our ability to manage healthcare operating expenses, our ability to achieve expected results from new business, the profitability, if any, of our capitated contracts or other products, increases or variations in cost of care, seasonality, CompCare's ability to obtain additional financing, increased outsourcing of behavioral health services, and additional risk factors as discussed in the reports filed by the company with the Securities and Exchange Commission, which are available on its website at www.sec.gov. Any forward- looking statement in this release speaks only as of the date on which it is made. CompCare assumes no obligation to update or revise any forward-looking statements.
Investor Contacts:
Paul Knopick
E & E Communications
pknopick@eandecommunications.com
940.262.3584

Published at www.investorideas.com newswire

Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas.com and its SMS partner Running Bull OTC have been compensated by HRDN for one month of news, email and sms: twenty five thousand
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Q&A Interview with Beverage Stock DC Brands (OTC: HRDN)

New York, New York - August 10, 2012 (Investorideas.com newswire, www.beveragestocks.com) Beverage stock news: Investorideas.com, releases an exclusive Q&A with Stephen F. Horgan, CEO of DC Brands International (OTC: HRDN), and Robert “Dr. Bob” Nikkel, Chief Herbologist. Mr. Horgan and Dr. Bob discuss the Company's product line and the growth strategy in the functional beverages and nutritional supplement categories.

Q: Investorideas.com staff
Investors aware of the growing global trend of eating and drinking healthier have watched the success of stocks like Whole Foods Market, Inc. (NasdaqGS :WFM) . Can you give investors some insight as to why your company chose to focus on the functional beverage and nutritional supplements sector?
A: Stephen F. Horgan, CEO (SFH)
The total non alcohol beverage market is over $110 Billion dollars in the US. Functional Beverages are approaching $15 Billion of that total. Our history is in nutritional supplements, which is where everything with our products emanates from. With the development of our proprietary flip-top cap delivery system, we were able to cross over into certain beverage occasions of nutrition conscious consumers. Our supplements provide a variety of solutions for these consumers looking for optimal nutrition delivery versus the minimal daily requirements. This is the case both with our dry line as well as our beverage line.
Q: Investorideas.com staff
You recently announced a distribution agreement that will potentially provide HARD Nutrition access to tens of thousands of retail outlets nationally. Can you give investors insight into the rollout of this agreement?
A: SFH
Our first priority will be to penetrate bell weather beverage markets geographically. This would mean Southern California initially, and eventually NYC. Our product has historically only been available in Colorado and it is time we moved outward from here to diversified markets with broader reach. Concurrently, we will begin speaking with national retailers about our products and the unique benefits it offers to their customers. The cycle on the former is much faster than on the latter so we would expect to see geographic progress ahead of national retail progress.
Q: Investorideas.com staff
Very few of the large domestic and international beverage companies have taken the steps to add stevia as a healthy sugar substitute. It appears to be a growing trend with some of the smaller niche beverage companies . Can you tell investors why you chose to have stevia added into your new reformulated drinks?
A: Dr.Bob Nikkel
The reason Hard Nutrition uses Stevia is because it is the only natural plant source that provides the sweetness taste in an all natural way without any calories, or side effects.
Q: Investorideas.com staff
In addition to your functional beverage product line you also have a wide array of nutritional supplements and vitamins to offer consumers. Can you give investors some insight on how you are continuing to develop and revamp these products?
A: Dr. Bob
We maintain a close watch on market and product developments as well as continually improving our products. Therefore are very aware of all new products, research their properties, constituencies and efficacy, and if we believe there is a component that can improve any of our formulas, in the interest of delivering consumer value and benefit, we will adapt as necessary.
Q: Investorideas.com staff
Can you explain to investors what sets your drinks apart from some of the larger health and vitamin beverage competitors?
A: Dr Bob.
The very obvious difference is that we deliver true functions, with all natural vitamins and herbal supplements for maximum efficacy. We have a patented delivery system that is distinctive and separates the beverage, or hydration aspect, and the dry supplement and vitamins. By doing this we deliver the function that the consumer desires, in a very flavorful and satisfying way.
When vitamins and supplements are added to the liquid the efficacy is reduced or even eliminated, due to heat applications for pasteurization. Moreover, the resultant taste of a drink when the vitamins and beverage are combined fails to meet the consumers expectations.
It is this unique and patented delivery flip-top cap system that really sets us apart. If you try to put enough nutrition in the drink you will get either a pungent and harsh taste, or so much masking flavor (sugar) will have to be added to make it taste pleasant that you negate the benefits the consumer is seeking. The maximum amount of nutrition that can be added into a drink is about 10% without resulting in a very harsh taste. This is why we separated the drink and the vitamin supplements in creating this first functional beverage system.
Q: Investorideas.com staff
In closing, can you give investors insight into your overall growth strategy for this year?
A: SFH
As soon as I began in June we immediately created 4 separate divisions for the company; Functional Beverage, Dry Supplements, Online and International. Although beverages will get most of the press, we expect that our Southern California and retail efforts in beverages will initially be enhanced by growth in our Dry Supplements and Online Divisions. International will be slower in developing and will take about a year before it will begin to contribute. We expect to be in the market with our new distinct, eye catching packaging in 30 days. We will also implement a very aggressive grass roots online, social media networking marketing approach to gain local consumers, and use that traction to expand the distribution network into other national markets that we believe have a consumer base that will embrace our nutritional dry and beverage products.
DC Brands International, a publicly traded company under the ticker symbol (HRDN), presently specializes in the manufacturing of its functional beverages and health products. Established in 1998, DC Brands began producing a number of lines of energy drinks in 2005. DC Brands then purchased the assets of H.A.R.D. Nutrition and began its quest to produce a new health line of products. DC Brands has recently announced the release of its new H.A.R.D. Nutrition Functional Water Systems, which it expects will revolutionize the functional beverage category. www.hardnutrition.com .
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
http://www.investorideas.com/About/Disclaimer.asp
Disclosure: Investorideas.com and its SMS partner Running Bull OTC have been compensated by HRDN for one month of news, email and sms: twenty five thousand
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
DC Brands is featured on Running Bull OTC for SMS alerts - sign up for the ap with your iphone or Android; Blackberry coming soon!
http://www.runningbullotc.com/
Contact HRDN: Wade Brantley
wbrantley@dc-brands.com
Contact Invesstorideas.com 800 665 0411
Source: Investorideas.com, DC Brands International

Tech Stock Alert: Fusion-io (NYSE:FIO) Soars on Fourth Quarter Results

New York, New York - August 10, 2012 (Investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research including tech stocks issues a trading and news alert for Fusion -io (NYSE:FIO) following fourth quarter results. The stock soared to a morning high of $27.48 and is trading at $27.15, up $6.13 or 29.16% as of 10:50AM EDT on over 10 Million shares. The 52- week high for the stock is $41.74.

Summary:

• Revenue: $359.3 million in fiscal 2012 (an increase of 82% over fiscal 2011)
• GAAP Net Loss per Diluted Share: 6 cents in fiscal 2012 (compared to earnings of 6 cents in fiscal 2011);
• Non-GAAP Net Earnings per Diluted Share: 35 cents in fiscal 2012 (compared to 20 cents in fiscal 2011)
• Operating Cash Flow: $34.8 million in fiscal 2012 (compared to a use of $9.9 million in fiscal 2011)
• GAAP Gross Margin of 57.5% and Non-GAAP Gross Margin of 57.6% for the fiscal fourth quarter 2012

About Fusion-io
Fusion-io delivers the world's data faster. Our Fusion ioMemory platform and software defined storage solutions accelerate virtualization, databases, cloud computing, big data and performance applications. From e-commerce retailers to the world's social media leaders and Fortune Global 500 companies, our customers are improving the performance and efficiency of their data centers with Fusion-io technology to accelerate the critical applications of the information economy.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts. Sectors include biotech stocks, tech stocks, beverage stocks, mining stocks, water, renewable energy, oil and gas.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access 13 online stock directories
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

IPO News Alert: Sports Fans Watch Manchester United (NYSE: MANU) Debut on New York Stock Exchange

New York, New York - August 10, 2012 (Investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research issues a trading alert for the market debut of Manchester United(NYSE :MANU), trading at $14.03, up 0.03(0.21%) at 10:28AM EDT on over 16 Million shares.
The Company’s IPO consisted of 16,666,667 Class A Ordinary Shares at a price of $14.00 per share.
About Manchester United
We are one of the most popular and successful sports teams in the world, playing one of the most popular spectator sports on Earth. Through our 134-year heritage we have won 60 trophies, enabling us to develop what we believe is one of the world’s leading brands and a global community of 659 million followers. Our large, passionate community provides Manchester United with a worldwide platform to generate significant revenue from multiple sources, including sponsorship, merchandising, product licensing, new media & mobile, broadcasting and matchday. We attract leading companies such as Nike, Aon and DHL that want access and exposure to our community of followers and association with our brand.
About InvestorIdeas.com:

InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts. Sectors include biotech stocks, tech stocks, beverage stocks, mining stocks, water, renewable energy, oil and gas.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access 13 online stock directories
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411
Source - www.Investorideas.com

Solar Stocks Trading Alert; MEMC Electronic Materials (NYSE:WFR) Gains on Second Quarter Results: Company Sees Improved Solar Business

New York, NY - August 9, 2012 (Investorideas.com renewable energy newswire) Investorideas.com, a leader in renewable energy stock research for independent investors, issues an investor trading alert for solar stock, MEMC Electronic Materials Inc. (NYSE :WFR), trading at $2.48, up 0.20(8.77%) following second quarter results.

Second Quarter 2012 Highlights:

• GAAP revenue of $808.4 million and GAAP EPS of ($0.27)
• Non-GAAP revenue of $933.4 million and non-GAAP EPS of $0.14
• Semiconductor Materials wafer volume grew 10% sequentially
• Solar Energy segment sold 169 MW of solar energy systems, interconnected 87 MW and ended the quarter with 104 MW under construction
• Cash and cash equivalents of $448.6 million at quarter end

Revenue in the second quarter of 2012 increased sequentially and year-over-year on improving conditions and operational execution in the company's semiconductor business, and stronger execution in a difficult environment in its solar energy business. Revenue in the company's Semiconductor Materials business grew sequentially driven by higher volume but declined year-over-year due to price erosion and lower volume. Solar Energy revenue rose sequentially and year over year on higher solar project sales. For the second quarter of 2012, SunEdison recognized non-GAAP revenue on 169 MW of solar energy systems sales, compared to 49 MW in the 2012 first quarter and 28 MW in the 2011 second quarter. Despite these increased solar energy systems sales, SunEdison's project pipeline remained flat at 2.9 GW.
About MEMC
MEMC is a global leader in semiconductor and solar technology. MEMC has been a pioneer in the design and development of silicon wafer technologies for over 50 years. With R&D and manufacturing facilities in the U.S., Europe, and Asia, MEMC enables the next generation of high performance semiconductor devices and solar cells. Through its SunEdison subsidiary, MEMC is also a developer of solar power projects and a worldwide leader in solar energy services. MEMC's common stock is listed on the New York Stock Exchange under the symbol "WFR." For more information about MEMC, please visit www.memc.com.
Research more cleantech stocks on global stock exchanges -and up to 1400 at Investorideas.com renewable energy stocks stock directory
About Investorideas.com - a leader in cleantech investor research
www.Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Follow Investorideas.com on Twitter
Follow Investorideas.com on Facebook
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 24/7 Login to 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks, tech and more.
Disclaimer/ Disclosure: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp Investorideas.com was not compensated for this report and does not hold a position in the stock
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
For more information about Investorideas.com
contact:
800.665.0411

Electric Car Stocks; EVCARCO, Inc. (OTCBB: EVCAD) Announces Management Change

FORT WORTH, TX – August 9, 2011 (Investorideas.com renewable energy/green newswire) - EVCARCO, Inc. (OTCBB:EVCA) announced today that Executive Vice President, Walter Speck has acquired a controlling interest in the Company. Mr. Speck has purchased 7,000,000 shares of Class B Convertible Preferred Stock from Nikolay Frolov, CFO and former Director of EVCA. Mr. Frolov recently resigned from the position of Director of the Company.

Mr. Gary Easterwood, President and CEO of EVCARCO/Third Stone Corporation has been appointed to the position of Director to fill the existing vacancy. Mr. Speck has been elected Chairman of the Board of the Company.
Mr. Speck commented, "This is an exciting development for EVCARCO and its subsidiary, The Third Stone Corporation. As Officer and Director, my objective will be to provide the leadership to put the Company on a path to success."
Mr. Easterwood stated, "The stock purchase finalizes the merger with EVCARCO and The Third Stone Corporation. Now that we have completed this step, we can begin implementing our plan to bring EVCA/The Third Stone Corporation to health and profitability. We will have exciting news to share with our stockholders in the coming weeks."
For more information on The Third Stone Corporation, Inc., please view: www.thirdstonecorp.com. Shareholder inquiries should be directed to (972) 571-1624.
For more information on EVCARCO, Inc., please view: www.evcarco.com. Shareholder inquiries should be directed to (972) 571-1624.
EVCARCO, Inc. is a Future Driven® Automotive Retail Group focused on deploying a coast-to-coast network of environmentally friendly franchised dealerships, vehicles, technologies and sustainable solutions. EVCARCO is bringing to market the most advanced clean technologies available in plug-in electric, alternative fuel, and pre-owned hybrid vehicles from multiple manufacturers. EVCARCO also owns The Third Stone Corporation, a forward-thinking software provider dedicated to improving and enhancing lives through innovations of software development and data services for sport, financial, home automation and social networking.
Forward-Looking Statement
This release contains forward-looking statements that reflect EVCARCO, Inc. plans and expectations. In this press release and related comments by Company management, words like "expect," "anticipate," "estimate," "forecast," "objective," "plan," "goal" and similar expressions are used to identify forward-looking statements, representing management's current judgment and expectations about possible future events. Management believes these forward-looking statements and the judgments upon which they are based to be reasonable, but they are not guarantees of future performance and involve numerous known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance, achievements or financial position to be materially different from any future results, performance, achievements or financial position expressed or implied by these forward-looking statements.
Contact:
Investor Relations
Jack Eversull
The Eversull Group, Inc.
972-571-1624
214-469-2361 fax

Published at the Investorideas.com Newswire

Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp. Investorideas.com Disclosure: Investorideas.com is compensated for publishing and distributing news for EVCA: five hundred thousand shares for a 3 month period starting July 27th 2012.
All investment involves risk. Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Biotech Stock Alert; Aethlon Medical (OTCBB: AEMD) Announces Expanded Access to Hemopurifier® Therapy For Individuals Infected with Hepatitis C Virus (HCV)

SAN DIEGO - August 9, 2012 (Investorideas.com newswire) - Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, announced today that it has agreed to establish a treatment program that will provide HCV-infected individuals with expanded access to Hemopurifier® therapy. The program is being initiated with support from the Institutional Review Board at the Medanta Medicity Institute (Medicity) to allow compassionate usage of the Aethlon Hemopurifier® for individuals who previously failed or subsequently relapsed standard-of-care drug regimens.

In addition to offering Hemopurifier® therapy to the citizens of India, HCV-infected individuals from the United States, European Union and other regions of the world may pursue treatment through the expanded access program. Details related to treatment protocol, inclusion criteria, patient approval processes and therapy pricing are anticipated in September. It is estimated that approximately 170 million people worldwide are infected with HCV, which leads to chronic liver disease or cirrhosis, and is a leading cause of liver transplantation.
The Aethlon Hemopurifier® is a first-in-class medical device that selectively targets the rapid clearance of HCV from the entire circulatory system to improve benefit, dose, duration and tolerability of drug therapies. The Medicity is a $360 million multi-specialty medical institute established to be a premier center for medical tourism in India.
"The Medicity access program represents an important milestone in our quest to establish the selective therapeutic filtration industry," stated Aethlon Chairman and CEO, Jim Joyce. "Beyond helping HCV-infected individuals overcome their disease, we now have the opportunity to augment our established government contract revenues with Hemopurifier® product sales."
Aethlon also disclosed that it will continue conducting a study at the Medicity that is evaluating the capability of the Aethlon Hemopurifier® to accelerate HCV RNA depletion at the outset of standard of care peginterferon+ribavirin (PR) therapy. Specifically, HCV-infected individuals are enrolled to receive up to three, six-hour Hemopurifier® treatments during the first three days of PR drug therapy. Last week, Aethlon reported that the two most recent HCV infected patients to receive Hemopurifier® therapy in combination with PR drug therapy achieved undetectable viral load at day-7, which is rarely reported in drug therapy alone.
The primary clinical endpoint of the Medicity protocol has been to increase the incidence of rapid virologic response (RVR), defined as undetectable HCV RNA at day 30 of therapy. RVR represents the clinical endpoint that best predicts treatment cure, otherwise known as sustained virologic response (SVR), defined as undetectable HCV RNA 24-weeks after the completion of PR drug therapy. As a point of reference, the landmark IDEAL Study of 3,070 HCV genotype-1 patients documented that only 10.35% (n=318/3070) of PR treated patients achieved a RVR. However, patients that achieved a RVR had SVR rates of 86.2% (n=274/318) versus SVR rates of 32.5% (n=897/2752) in non-RVR patients. While the incidence of undetectable HCV RNA at day-7 is not reported in the IDEAL study, the study did reveal that just 4.3% (n=131/3070) of patients achieved undetectable HCV RNA at day-14, which equated to a 91% (n=118/131) SVR rate.
Aethlon reported that Hemopurifier® therapy has been well tolerated and without device-related adverse events in ten treated patients. Of these ten patients, seven patients were infected with HCV genotype-1; two patients were infected with HCV genotype-3; and one patient was infected with HCV genotype-5. At present, undetectable HCV RNA is reported in eight of the 10 treated patients. Of the two patients with detectable HCV RNA, one discontinued PR therapy as a result of a diabetes related condition. HCV RNA is undetectable in all patients (n=4) that have been monitored for 48 weeks since receiving Hemopurifier® therapy. Among the 10 treated patients, Aethlon reported that six genotype-1 patients received the three treatment Hemopurifier® protocol, which resulted in four (67%) patients achieving a RVR. The IDEAL study predicts it would normally require approximately 40 PR treated patients to achieve 4 RVR outcomes. Both patients who achieved undetectable HCV RNA at day-7 also achieved a RVR. Beyond the high likelihood of a SVR, genotype-1 patients that achieve a RVR also have the opportunity to reduce the duration of PR drug therapy from 48 weeks to 24 weeks.
In addition to expanding access to Hemopurifier® therapy at the Medicity, Aethlon is preparing to resubmit to the FDA an investigational device exemption (IDE), which will incorporate the Medicity data in an effort to gain approval to initiate HCV clinical programs in the United States.

About Aethlon Medical
The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer; HER2osome™ to target HER2+ breast cancer, and a medical device being developed under a contract with the Defense Advanced Research Projects Agency (DARPA) that would reduce the incidence of sepsis in combat-injured soldiers and civilians. For more information, please visit www.aethlonmedical.com.
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the ability for the Company to derive business partnerships or future revenue streams using the Aethlon ADAPT™ system including the ability to introduce a targeted breast cancer therapy known as HER2osome™, there is no assurance that FDA will approve the initiation of the company's clinical programs or provide market clearance of the company's products, the ability to achieve the goals set out in the DARPA contract, future human studies of the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer therapies, the company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.
Contacts:
James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
Marc Robins
877.276.2467
mr@aethlonmedical.com
Visit the AETHLON MEDICAL INC (OTC BB: AEMD) showcase profile page on Investorideas.comDisclosure/Disclaimer: AETHLON MEDICAL INC (OTC BB: AEMD) Investorideas.com is paid by AEMD to publish news and distribute content through Investordeas.com Newswire and its syndicated partners and blogs

IPO Trading Alert: Bloomin' Brands (NASDAQ:BLMN) Gains in Market Debut

New York, NY - August 8, 2012 (Investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research including food and beverage stocks reports on the IPO market debut for Bloomin' Brands Inc. (NASDAQ: BLMN). The stock is trading at $12.31, up 1.31(11.95%) 11:13AM EDT on over 6.5 Million shares.
The IPO consisted of 16,000,000 shares at $11.00 per share; 13,000,000 shares from the Company and certain selling stockholders will offer 3,000,000 shares.

About Bloomin' Brands Inc. (NASDAQ: BLMN)
Bloomin' Brands is a portfolio of brands comprised of Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, Fleming's Prime Steakhouse & Wine Bar and Roy's with more than 1,400 restaurants in 48 states and 20 countries and territories internationally
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
Become an Investorideas.com Member and access 13 online stock directories
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Nanotechnology Stocks; mPhase (OTC.BB:XDSL) to Explore Possibility of Complementing Its Smart NanoBattery With New Printing Technologies Utilizing Graphene and Other Advanced Materials

LITTLE FALLS, NJ - August 7, 2012 (Investorideas.com Newswire) - mPhase Technologies, Inc. (OTC.BB: XDSL.OB) said today that it is exploring complementing its Smart NanoBattery with new printing technologies utilizing Graphene and other advanced new materials.

On July 17, 2012, mPhase announced an official agreement to jointly pursue business opportunities with government projects involving the research of Graphene based methods for the ink jet printing of batteries and electronic circuits with a leading technology University.
Successfully implementing mPhase's Smart NanoBattery Technology with new material and printing technologies could lead to better energy densities, more flexible structures, lower prototyping costs and lower production costs.
Graphene has been described as the "miracle material" of the 21st Century and is believed to be stronger than steel and more conductive than copper while being flexible, making it plausible as a vast improvement over silicon possibly leading to thinner, faster, cheaper, more flexible devices including power sources. Since Graphene comes from the carbon atom it is abundant and cheap.
In 2010 the Nobel Prize in Physics was awarded to Andre Geim and Konstantin Novoselov for groundbreaking experiments regarding graphene.
For more information on graphene:
BBC News - Is graphene a miracle material?
About mPhase Technologies, Inc.
mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and microfluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery. In addition to the Smart Surface technology, mPhase recently introduced its first product, the mPower Emergency Illuminator, an award-winning product designed by Porsche Design Studio and sold via the mPower website: http://www.mPhaseTech.com.
Forward-Looking Statements
As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company's SEC filings, including the financial statements and related information contained in the Company's SEC Filing. mPhase assumes no obligation to update the information in this release.
Contact:
973-256-3737
mPhase Technologies, Inc.

Visit the XDSL showcase profile at Investorideas.com
Request News and Info on XDSL
Disclosure, Disclaimer/ XDSL is a paid advertising client on Investorideas.com and our technology portals.

Beverage Stock Interview with DC Brands (OTC: HRDN); Revolutionizing the Functional Beverage Market

New York, New York - August 8, 2012 (Investorideas.com newswire, www.beveragestocks.com) Investorideas.com, an investor research portal specializing in sector research including beverage and health stocks issues an exclusive Q&A with Stephen F. Horgan, CEO of DC Brands International (OTC: HRDN) , and Robert “Dr. Bob” Nikkel, Chief Herbologist. Mr. Horgan and Dr. Bob discuss the Company’s product line and the growth strategy in the functional beverages and nutritional supplement categories.

Q: Investorideas.com staff
Investors aware of the growing global trend of eating and drinking healthier have watched the success of stocks like Whole Foods Market, Inc. (NasdaqGS :WFM) . Can you give investors some insight as to why your company chose to focus on the functional beverage and nutritional supplements sector?
A: Stephen F. Horgan, CEO (SFH)
The total non alcohol beverage market is over $110 Billion dollars in the US. Functional Beverages are approaching $15 Billion of that total. Our history is in nutritional supplements, which is where everything with our products emanates from. With the development of our proprietary flip-top cap delivery system, we were able to cross over into certain beverage occasions of nutrition conscious consumers. Our supplements provide a variety of solutions for these consumers looking for optimal nutrition delivery versus the minimal daily requirements. This is the case both with our dry line as well as our beverage line.
Q: Investorideas.com staff
You recently announced a distribution agreement that will potentially provide HARD Nutrition access to tens of thousands of retail outlets nationally. Can you give investors insight into the rollout of this agreement?
A: SFH
Our first priority will be to penetrate bell weather beverage markets geographically. This would mean Southern California initially, and eventually NYC. Our product has historically only been available in Colorado and it is time we moved outward from here to diversified markets with broader reach. Concurrently, we will begin speaking with national retailers about our products and the unique benefits it offers to their customers. The cycle on the former is much faster than on the latter so we would expect to see geographic progress ahead of national retail progress.
Q: Investorideas.com staff
Very few of the large domestic and international beverage companies have taken the steps to add stevia as a healthy sugar substitute. It appears to be a growing trend with some of the smaller niche beverage companies . Can you tell investors why you chose to have stevia added into your new reformulated drinks?
A: Dr.Bob Nikkel
The reason Hard Nutrition uses Stevia is because it is the only natural plant source that provides the sweetness taste in an all natural way without any calories, or side effects.
Q: Investorideas.com staff
In addition to your functional beverage product line you also have a wide array of nutritional supplements and vitamins to offer consumers. Can you give investors some insight on how you are continuing to develop and revamp these products?
A: Dr. Bob
We maintain a close watch on market and product developments as well as continually improving our products. Therefore are very aware of all new products, research their properties, constituencies and efficacy, and if we believe there is a component that can improve any of our formulas, in the interest of delivering consumer value and benefit, we will adapt as necessary.
Q: Investorideas.com staff
Can you explain to investors what sets your drinks apart from some of the larger health and vitamin beverage competitors?
A: Dr Bob.
The very obvious difference is that we deliver true functions, with all natural vitamins and herbal supplements for maximum efficacy. We have a patented delivery system that is distinctive and separates the beverage, or hydration aspect, and the dry supplement and vitamins. By doing this we deliver the function that the consumer desires, in a very flavorful and satisfying way.
When vitamins and supplements are added to the liquid the efficacy is reduced or even eliminated, due to heat applications for pasteurization. Moreover, the resultant taste of a drink when the vitamins and beverage are combined fails to meet the consumers expectations.
It is this unique and patented delivery flip-top cap system that really sets us apart. If you try to put enough nutrition in the drink you will get either a pungent and harsh taste, or so much masking flavor (sugar) will have to be added to make it taste pleasant that you negate the benefits the consumer is seeking. The maximum amount of nutrition that can be added into a drink is about 10% without resulting in a very harsh taste. This is why we separated the drink and the vitamin supplements in creating this first functional beverage system.
Q: Investorideas.com staff
In closing, can you give investors insight into your overall growth strategy for this year?
A: SFH
As soon as I began in June we immediately created 4 separate divisions for the company; Functional Beverage, Dry Supplements, Online and International. Although beverages will get most of the press, we expect that our Southern California and retail efforts in beverages will initially be enhanced by growth in our Dry Supplements and Online Divisions. International will be slower in developing and will take about a year before it will begin to contribute. We expect to be in the market with our new distinct, eye catching packaging in 30 days. We will also implement a very aggressive grass roots online, social media networking marketing approach to gain local consumers, and use that traction to expand the distribution network into other national markets that we believe have a consumer base that will embrace our nutritional dry and beverage products.
DC Brands International, a publicly traded company under the ticker symbol (HRDN), presently specializes in the manufacturing of its functional beverages and health products. Established in 1998, DC Brands began producing a number of lines of energy drinks in 2005. DC Brands then purchased the assets of H.A.R.D. Nutrition and began its quest to produce a new health line of products. DC Brands has recently announced the release of its new H.A.R.D. Nutrition Functional Water Systems, which it expects will revolutionize the functional beverage category. www.hardnutrition.com .
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
http://www.investorideas.com/About/Disclaimer.asp
Disclosure: Investorideas.com and its SMS partner Running Bull OTC have been compensated by HRDN for one month of news, email and sms: twenty five thousand
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
DC Brands is featured on Running Bull OTC for SMS alerts - sign up for the ap with your iphone or Android; Blackberry coming soon!
http://www.runningbullotc.com/
Contact HRDN: Wade Brantley
wbrantley@dc-brands.com
Contact Invesstorideas.com 800 665 0411
Source: Investorideas.com, DC Brands International

Biodefense Stock News; Northrop Grumman (NYSE:NOC) and PositiveID (OTCBB: PSID) Prepare for BioWatch Procurement

New York, New York - August 6, 2012 (Investorideas.com newswire, www.biodefensestocks.com) Investorideas.com, a leader in research for independent investors issues a news alert for biodefense stocks, PositiveID Corporation (OTCBB: PSID) and Northrop Grumman Corporation (NYSE:NOC) as both companies prepare for technology acquisitions and procurement for BioWatch Generation 3 this fall.

PositiveID Corporation (OTCBB: PSID) recently reported it added Dr. Kimothy Smith as Chief Technology Advisor to the Company and its Microfluidic Systems ("MFS") subsidiary. The Company will utilize Dr. Smith's expertise in the areas of biosurveillance, biodefense, biosecurity, molecular genetics and diagnostics, as it prepares for the release of the final request for proposal from the Department of Homeland Security ("DHS") for BioWatch Generation 3,  a $3.1 billion procurement for an early warning system designed to detect the intentional release of airborne biological agents. The Company believes its M-BAND system is one of the only technologies capable of addressing the requirements of BioWatch Generation 3.
In July Northrop Grumman Corporation (NYSE:NOC) reported  that its Next Generation Automated Detection System (NG-ADS) for homeland defense applications has successfully completed a rigorous field test and is ready for the program's next phase.
The NG-ADS technology is a competitor for the Department of Homeland Security's (DHS) upcoming BioWatch Gen-3 Phase II acquisition. The program seeks to deploy a nationwide network of fully autonomous bio-detectors in major metropolitan areas across the United States to provide early warning of a biological attack. DHS recently announced that a request for proposals will be issued later this year.
As a fully automated biological detection system, the NG-ADS continuously collects air samples, analyzes the samples for the presence of multiple biological pathogens, and automatically reports results to public health officials multiple times each day through a secure data network. More than 20,000 samples were collected and analyzed during the recent field test in a variety of indoor and outdoor locations in a major city in the United States .
"There are concerns that our nation won't be ready to respond should a biological attack occur," said Dave Tilles, director of Homeland Security programs at Northrop Grumman's Electronic Systems sector. "Early warning provided by an automated detection system such as the NG-ADS will allow the nation's public health and public safety officials to proactively manage the response to a biological event to reduce exposure and treat the affected population to minimize casualties."
Since the successful field test, additional improvements have been made to the NG-ADS to enhance the system's performance while reducing its life-cycle cost. The proven, life-saving capability of the NG-ADS draws upon Northrop Grumman's decade long experience developing, testing, deploying, and operating bio-detection systems for the U.S. government and other customers.
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of advanced technologies for diabetes management and rapid medical testing, as well as airborne bio-threat detection systems for America 's homeland defense. Its wholly-owned subsidiary, Microfluidic Systems, or MFS, is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. www.PositiveIDCorp.com.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Read Investorideas.com on Linkedin.com/today
http://www.linkedin.com/today/investorideas.com
Get free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer /Disclosure: Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. .More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: PositiveID Corporation  compensates Investorideas.com for news release publication, syndication on blogs and related sites and email distribution and  company profile: renewed July 2012 -3500 cash and five hundred thousand shares for three months http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Contact
PSID:
Allison Tomek
561-805-8000
atomek@positiveidcorp.com
Investorideas.com:
Contact: 800 665 0411

Investorideas.com News now Featured on Linkedin.com/Today

New York, New York - August 6, 2012 (Investorideas.com newswire) Investorideas.com, an investor research portal specializing in sector research for independent investors is pleased to report the Investorideas.com news content is now featured on Linkedin.com/today . Investorideas.com is now an approved news and publishing source at Linkedin.com/today.

http://www.linkedin.com/today/ investorideas.com
About http://www.linkedin.com/today/
The day's top news, tailored for you
About LinkedIn (LNKD)
Founded in 2003, LinkedIn connects the world's professionals to make them more productive and successful. With more than 175 million members worldwide, including executives from every Fortune 500 company, LinkedIn is the world's largest professional network on the Internet. The company has a diversified business model with revenue coming from member subscriptions, marketing solutions and hiring solutions. Headquartered in Silicon Valley, LinkedIn also has offices across the Americas, Europe, and the Asia-Pacific.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; water and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, natural gas stocks, tech (includes cloud and social networking), defense stocks, nanotech, China stocks and agriculture.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Sign up for the free investor news letter and stock alerts at Investorideas.com http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The Investorideas.com wire is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investment involves risk and potential loss of all investment
Contact Investorideas.com
800 665 0411